<![CDATA[Invivoscribe, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=14810>Fri, 01 May 2026 02:02:58 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Invivoscribe Announces the PrepQuant™ System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows]]>https://www.newswire.co.kr/newsRead.php?no=1032488Thu, 16 Apr 2026 15:30:00 +0900<![CDATA[인비보스크라이브, 프렙퀀트™ 시스템 발표… 전처리 워크플로를 표준화하고 간소화하는 통합 샘플 준비 플랫폼]]>https://www.newswire.co.kr/newsRead.php?no=1032489Thu, 16 Apr 2026 15:30:00 +0900<![CDATA[Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification]]>https://www.newswire.co.kr/newsRead.php?no=1031195Fri, 27 Mar 2026 11:10:00 +0900<![CDATA[인비보스크라이브®, 아이덴티클론® Dx IGH 분석 인증으로 IVDR 포트폴리오 확장]]>https://www.newswire.co.kr/newsRead.php?no=1031196Fri, 27 Mar 2026 11:10:00 +0900<![CDATA[Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide]]>https://www.newswire.co.kr/newsRead.php?no=1028326Fri, 06 Feb 2026 11:40:00 +0900<![CDATA[인비보스크라이브 ‘류코스트랫 KMT2A + MRD 분석법’ 출시… 전 세계 임상시험 및 환자 관리에서 고감도 백혈병 검사 발전 도모]]>https://www.newswire.co.kr/newsRead.php?no=1028327Fri, 06 Feb 2026 11:40:00 +0900<![CDATA[Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial]]>https://www.newswire.co.kr/newsRead.php?no=1014589Wed, 09 Jul 2025 10:45:00 +0900<![CDATA[인비보스크라이브, CAR-T 면역치료 개발 및 규제 준비 가속화 위해 유세포 분석 서비스 확대… CERo 테라퓨틱스 임상 1상 시험 개시]]>https://www.newswire.co.kr/newsRead.php?no=1014590Wed, 09 Jul 2025 10:45:00 +0900<![CDATA[LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials]]>https://www.newswire.co.kr/newsRead.php?no=1013400Thu, 19 Jun 2025 10:15:00 +0900<![CDATA[LabPMM®, NPM1 MRD 분석에 대한 뉴욕주 승인 획득… 요법 설명 및 표적 임상시험 가속화]]>https://www.newswire.co.kr/newsRead.php?no=1013403Thu, 19 Jun 2025 10:15:00 +0900<![CDATA[Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay]]>https://www.newswire.co.kr/newsRead.php?no=1009932Wed, 23 Apr 2025 15:00:00 +0900<![CDATA[인비보스크라이브 LabPMM, FLT3 ITD MRD 애세이 뉴욕주 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=1009935Wed, 23 Apr 2025 15:00:00 +0900<![CDATA[Invivoscribe Announces Registration of the LeukoStrat® CDx FLT3 Mutation Assay in the United Kingdom and Switzerland]]>https://www.newswire.co.kr/newsRead.php?no=1008376Fri, 28 Mar 2025 16:15:00 +0900<![CDATA[인비보스크라이브, LeukoStrat® CDx FLT3 뮤테이션 애세이의 영국 및 스위스 등록 발표]]>https://www.newswire.co.kr/newsRead.php?no=1008377Fri, 28 Mar 2025 16:15:00 +0900<![CDATA[EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA]]>https://www.newswire.co.kr/newsRead.php?no=998248Wed, 09 Oct 2024 12:25:00 +0900<![CDATA[EU 인증 기관(BSI 네덜란드) 및 EMA, 유럽연합 및 유럽경제지역에서 EU 및 EEA에서 반플라타® 요법을 위한 류코스트랫® CDx FLT3 돌연변이 분석법 승인]]>https://www.newswire.co.kr/newsRead.php?no=998249Wed, 09 Oct 2024 12:25:00 +0900<![CDATA[Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML]]>https://www.newswire.co.kr/newsRead.php?no=989453Thu, 09 May 2024 13:55:00 +0900<![CDATA[급성 골수성 백혈병에서 관해 잔류 FLT3-ITD 돌연변이와 이식 후 결과 간의 중요한 연관성을 시사하는 연구 공개]]>https://www.newswire.co.kr/newsRead.php?no=989455Thu, 09 May 2024 13:55:00 +0900<![CDATA[Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use]]>https://www.newswire.co.kr/newsRead.php?no=929846Fri, 03 Sep 2021 15:45:00 +0900<![CDATA[로즈웰파크종합암센터, Invivoscribe와 LymphoTrack 소프트웨어 라이선스 체결]]>https://www.newswire.co.kr/newsRead.php?no=929847Fri, 03 Sep 2021 15:45:00 +0900<![CDATA[Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China]]>https://www.newswire.co.kr/newsRead.php?no=927610Fri, 23 Jul 2021 13:30:00 +0900<![CDATA[Invivoscribe, EU 주요 서브미션 및 중국 역량 강화 발표]]>https://www.newswire.co.kr/newsRead.php?no=927611Fri, 23 Jul 2021 13:30:00 +0900<![CDATA[Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System]]>https://www.newswire.co.kr/newsRead.php?no=926012Fri, 25 Jun 2021 15:40:00 +0900<![CDATA[Invivoscribe, 시퀀싱 기반 면역 체계 분석 애플리케이션 뒷받침할 교부 프로그램 출시]]>https://www.newswire.co.kr/newsRead.php?no=926013Fri, 25 Jun 2021 15:40:00 +0900<![CDATA[Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China]]>https://www.newswire.co.kr/newsRead.php?no=925043Wed, 09 Jun 2021 17:30:00 +0900